Tumor blood flow changes induced by chemical modifiers of radiation response
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (3) , 459-462
- https://doi.org/10.1016/0360-3016(92)90853-a
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitationsRadiotherapy and Oncology, 1991
- The Effect of Therapy on Tumour Vascular FunctionInternational Journal of Radiation Biology, 1991
- Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1989
- The effects of melphalan and misonidazole on the vasculature of a murine sarcomaBritish Journal of Cancer, 1987
- Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)British Journal of Cancer, 1986
- Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferaseBritish Journal of Cancer, 1986
- Cell selection from a murine tumour using the fluorescent probe Hoechst 33342British Journal of Cancer, 1985
- Extracellular PH and weak acid/weak base drug uptake and cytotoxicityInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Systemic hypertension: A complication of intra-arterial cis-diammine dichloroplatinum (II) infusionCancer, 1981
- Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1980